All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.

Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic ...

The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.

We, the independent directors of the 23andMe Board, hereby tender our resignations, effective immediately.

In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference of view with you” about the company’s future.

All seven independent directors of 23andMe resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the ...

All seven of the independent directors on 23andme's (ME) board have resigned as the CEO Anne Wojcicki plans to take the company private. This news comes as the biotech company agreed to pay $30 ...

Aug. 02, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today sent the ...

A proposal by 23andMe founder and chief executive Anne Wojcicki to take the genetic testing company private has been rejected by a special committee of the board of directors. The success of ...

In the settlement, 23andMe called the deal "fair, adequate and reasonable". How 23andMe board reacted to CEO's buyout offer Spit take-private: 23andMe founder has a plan Spit take-private ...

Why 23andMe pulled the plug on its drug-discovery unit How 23andMe board reacted to CEO's buyout offer Related: How 23andMe board reacted to CEO's buyout offer ...